FP7
BIOVACSAFE
Biomarkers For Enhanced Vaccine Safety
- Programme
- Seventh Framework Programme
- Started
- Ends
- Duration
- 78 months
- Total cost
- EUR 30,931,370
- EU contribution
- EUR 17,408,770
- Participants
- 21 from 10 countries
- Topic
- FP7_IMI-JU-03-2010-03
- Grant agreement
- 115308
Coordinated by Glaxosmithkline Vaccines SRL (ITItaly).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Glaxosmithkline Vaccines SRL | ITItaly | Coordinator | Not stated | PIC (1.00) |
| Cdisc Europe Foundation Fondation | BEBelgium | Participant | Not stated | PIC (1.00) |
| Glaxosmithkline Biologicals SA | BEBelgium | Participant | Not stated | PIC (1.00) |
| Universiteit Gent | BEBelgium | Participant | EUR 2,000,007 | known name (0.95) |
| Charite - Universitaetsmedizin Berlin | DEGermany | Participant | EUR 356,306 | PIC (1.00) |
| Max-Planck-Gesellschaft Zur Forderung der Wissenschaften Ev | DEGermany | Participant | EUR 2,531,522 | known name (0.95) |
| Statens Serum Institut | DKDenmark | Participant | EUR 679,216 | known name (0.95) |
| Sanofi Pasteur SA | FRFrance | Participant | Not stated | PIC (1.00) |
| Department of Health | GBUnited Kingdom | Participant | EUR 497,736 | known name (0.95) |
| Health Protection Agency Hpa | GBUnited Kingdom | Participant | EUR 566 | PIC (1.00) |
| Imperial College of Science Technology and Medicine | GBUnited Kingdom | Participant | EUR 2,336,660 | PIC (1.00) |
| Liverpool School of Tropical Medicine | GBUnited Kingdom | Participant | EUR 216,203 | known name (0.95) |
| St George's Hospital Medical School | GBUnited Kingdom | Participant | EUR 315,031 | PIC (1.00) |
| University of Surrey | GBUnited Kingdom | Participant | EUR 3,711,632 | known name (0.95) |
| ImmunArray Ltd | ILIsrael | Participant | EUR 925,820 | PIC (1.00) |
| Islensk Erfdagreining Ehf | ISIceland | Participant | EUR 29,786 | PIC (1.00) |
| Universita Degli Studi di Siena | ITItaly | Participant | EUR 1,029,564 | known name (0.95) |
| Vismederi SRL | ITItaly | Participant | Not stated | PIC (1.00) |
| Universiteit Utrecht | NLNetherlands | Participant | EUR 839,510 | known name (0.95) |
| Chalmers Tekniska Hogskola AB | SESweden | Participant | EUR 762,212 | PIC (1.00) |
| Goeteborgs Universitet | SESweden | Participant | EUR 777,000 | PIC (1.00) |
Changes of the consortium
First seen on with 21 participants from 10 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.